Literature DB >> 22247482

A connexin40 mutation associated with a malignant variant of progressive familial heart block type I.

Naomasa Makita1, Akiko Seki, Naokata Sumitomo, Halina Chkourko, Shigetomo Fukuhara, Hiroshi Watanabe, Wataru Shimizu, Connie R Bezzina, Can Hasdemir, Hideo Mugishima, Takeru Makiyama, Alban Baruteau, Estelle Baron, Minoru Horie, Nobuhisa Hagiwara, Arthur A M Wilde, Vincent Probst, Hervé Le Marec, Dan M Roden, Naoki Mochizuki, Jean-Jacques Schott, Mario Delmar.   

Abstract

BACKGROUND: Progressive familial heart block type I (PFHBI) is a hereditary arrhythmia characterized by progressive conduction disturbances in the His-Purkinje system. PFHBI has been linked to genes such as SCN5A that influence cardiac excitability but not to genes that influence cell-to-cell communication. Our goal was to explore whether nucleotide substitutions in genes coding for connexin proteins would associate with clinical cases of PFHBI and if so, to establish a genotype-cell phenotype correlation for that mutation. METHODS AND
RESULTS: We screened 156 probands with PFHBI. In addition to 12 sodium channel mutations, we found a germ line GJA5 (connexin40 [Cx40]) mutation (Q58L) in 1 family. Heterologous expression of Cx40-Q58L in connexin-deficient neuroblastoma cells resulted in marked reduction of junctional conductance (Cx40-wild type [WT], 22.2±1.7 nS, n=14; Cx40-Q58L, 0.56±0.34 nS, n=14; P<0.001) and diffuse localization of immunoreactive proteins in the vicinity of the plasma membrane without formation of gap junctions. Heteromeric cotransfection of Cx40-WT and Cx40-Q58L resulted in homogenous distribution of proteins in the plasma membrane rather than in membrane plaques in ≈50% of cells; well-defined gap junctions were observed in other cells. Junctional conductance values correlated with the distribution of gap junction plaques.
CONCLUSIONS: Mutation Cx40-Q58L impairs gap junction formation at cell-cell interfaces. This is the first demonstration of a germ line mutation in a connexin gene that associates with inherited ventricular arrhythmias and emphasizes the importance of Cx40 in normal propagation in the specialized conduction system.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22247482      PMCID: PMC4274644          DOI: 10.1161/CIRCEP.111.967604

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  23 in total

1.  Cardiac conduction defects associate with mutations in SCN5A.

Authors:  J J Schott; C Alshinawi; F Kyndt; V Probst; T M Hoorntje; M Hulsbeek; A A Wilde; D Escande; M M Mannens; H Le Marec
Journal:  Nat Genet       Date:  1999-09       Impact factor: 38.330

2.  ETIOLOGY AND PATHOLOGY OF BILATERAL BUNDLE BRANCH BLOCK IN RELATION TO COMPLETE HEART BLOCK.

Authors:  J LENEGRE
Journal:  Prog Cardiovasc Dis       Date:  1964-03       Impact factor: 8.194

3.  Mouse model of SCN5A-linked hereditary Lenègre's disease: age-related conduction slowing and myocardial fibrosis.

Authors:  Anne Royer; Toon A B van Veen; Sabrina Le Bouter; Céline Marionneau; Violaine Griol-Charhbili; Anne-Laure Léoni; Marja Steenman; Harold V M van Rijen; Sophie Demolombe; Catharine A Goddard; Christine Richer; Brigitte Escoubet; Thérèse Jarry-Guichard; William H Colledge; Daniel Gros; Jacques M T de Bakker; Andrew A Grace; Denis Escande; Flavien Charpentier
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

4.  The pathogenesis of atrioventricular block in coronary disease.

Authors:  M Lev; S G Kinare; A Pick
Journal:  Circulation       Date:  1970-09       Impact factor: 29.690

5.  Loss of electrical communication, but not plaque formation, after mutations in the cytoplasmic loop of connexin43.

Authors:  Akiko Seki; Wanda Coombs; Steven M Taffet; Mario Delmar
Journal:  Heart Rhythm       Date:  2004-07       Impact factor: 6.343

6.  Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenègre disease.

Authors:  Vincent Probst; Florence Kyndt; Franck Potet; Jean-Noel Trochu; Guy Mialet; Sophie Demolombe; Jean-Jacques Schott; Isabelle Baró; Denis Escande; Hervé Le Marec
Journal:  J Am Coll Cardiol       Date:  2003-02-19       Impact factor: 24.094

7.  An isolated cardiac conduction disease maps to chromosome 19q.

Authors:  A de Meeus; E Stephan; S Debrus; M K Jean; J Loiselet; J Weissenbach; J Demaille; P Bouvagnet
Journal:  Circ Res       Date:  1995-10       Impact factor: 17.367

8.  Architectural and functional asymmetry of the His-Purkinje system of the murine heart.

Authors:  Lucile Miquerol; Sonia Meysen; Matteo Mangoni; Patrick Bois; Harold V M van Rijen; Patrice Abran; Habo Jongsma; Joël Nargeot; Daniel Gros
Journal:  Cardiovasc Res       Date:  2004-07-01       Impact factor: 10.787

9.  SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia.

Authors:  William P McNair; Lisa Ku; Matthew R G Taylor; Pam R Fain; Dmi Dao; Eugene Wolfel; Luisa Mestroni
Journal:  Circulation       Date:  2004-10-04       Impact factor: 29.690

10.  Gene for progressive familial heart block type I maps to chromosome 19q13.

Authors:  P A Brink; A Ferreira; J C Moolman; H W Weymar; P L van der Merwe; V A Corfield
Journal:  Circulation       Date:  1995-03-15       Impact factor: 29.690

View more
  14 in total

1.  Perturbation of chemical coupling by an endothelial Cx40 mutant attenuates endothelium-dependent vasodilation by KCa channels and elevates blood pressure in mice.

Authors:  Daniel J Chaston; Rebecca E Haddock; Lauren Howitt; Susan K Morton; Russell D Brown; Klaus I Matthaei; Caryl E Hill
Journal:  Pflugers Arch       Date:  2014-11-05       Impact factor: 3.657

2.  Feasibility of analysis of the SCN5A gene in paraffin embedded samples in sudden infant death cases at the Pretoria Medico-Legal Laboratory, South Africa.

Authors:  Barbara Ströh van Deventer; Lorraine du Toit-Prinsloo; Chantal van Niekerk
Journal:  Forensic Sci Med Pathol       Date:  2018-06-16       Impact factor: 2.007

Review 3.  Purkinje physiology and pathophysiology.

Authors:  Penelope A Boyden
Journal:  J Interv Card Electrophysiol       Date:  2018-07-28       Impact factor: 1.900

4.  Genotypic and phenotypic predictors of complete heart block and recovery of conduction after surgical repair of congenital heart disease.

Authors:  Laura E Murray; Andrew H Smith; English C Flack; Kim Crum; Jill Owen; Prince J Kannankeril
Journal:  Heart Rhythm       Date:  2016-11-05       Impact factor: 6.343

5.  Absence of family history and phenotype-genotype correlation in pediatric Brugada syndrome: more burden to bear in clinical and genetic diagnosis.

Authors:  Houria Daimi; Amel Haj Khelil; Khaldoun Ben Hamda; Amelia Aranega; Jemni B E Chibani; Diego Franco
Journal:  Pediatr Cardiol       Date:  2015-03-11       Impact factor: 1.655

Review 6.  Current perspectives in genetic cardiovascular disorders: from basic to clinical aspects.

Authors:  Masa-aki Kawashiri; Kenshi Hayashi; Tetsuo Konno; Noboru Fujino; Hidekazu Ino; Masakazu Yamagishi
Journal:  Heart Vessels       Date:  2013-08-02       Impact factor: 2.037

Review 7.  Prenatal diagnosis and management of congenital complete heart block.

Authors:  Jay D Pruetz; Jennifer C Miller; Gerald E Loeb; Michael J Silka; Yaniv Bar-Cohen; Ramen H Chmait
Journal:  Birth Defects Res       Date:  2019-03-01       Impact factor: 2.344

Review 8.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 9.  Cell junctions in the specialized conduction system of the heart.

Authors:  Valeria Mezzano; Jason Pellman; Farah Sheikh
Journal:  Cell Commun Adhes       Date:  2014-04-16

10.  Transcriptome signature of ventricular arrhythmia in dilated cardiomyopathy reveals increased fibrosis and activated TP53.

Authors:  Mary E Haywood; Andrea Cocciolo; Kadijah F Porter; Evgenia Dobrinskikh; Dobromir Slavov; Sharon L Graw; T Brett Reece; Amrut V Ambardekar; Michael R Bristow; Luisa Mestroni; Matthew R G Taylor
Journal:  J Mol Cell Cardiol       Date:  2020-01-18       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.